1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Global Smoking Cesation Partnering 2010-2015

Global Smoking Cesation Partnering 2010-2015

  • July 2015
  • -
  • Currentpartnering
  • -
  • 100 pages

The Global Smoking Cessation Partnerning 2010-2015 report provides understanding and access to the smoking cessation partnering deals and agreements entered into by the worlds leading healthcare companies .The Smoking Cessation Partnering 2010-2015 report provides understanding and access to the smoking cessation partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in smoking cessation partnering deals
Top smoking cessation deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

The Smoking Cessation Partnering 2010-2015 provides understanding and access to the smoking cessation partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of smoking cessation partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors smoking cessation technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 25 links to online copies of actual smoking cessation deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of smoking cessation partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of smoking cessation technologies and products.

Report scope

Smoking Cessation Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to smoking cessation trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in smoking cessation dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 25 smoking cessation deals
The leading smoking cessation deals by value since 2010

In Smoking Cessation Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.Smoking Cessation Partnering 2010-2015 provides the reader with the following key benefits:

In-depth understanding of smoking cessation deal trends since 2010
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 25 actual smoking cessation deals entered into by the world’s biopharma companies since 2010
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table Of Contents

Global Smoking Cesation Partnering 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in smoking cessation partnering

2.1. Introduction
2.2. Smoking cessation partnering over the years
2.3. Smoking cessation partnering by deal type
2.4. Smoking cessation partnering industry sector
2.5. Smoking cessation partnering by stage of development
2.6. Smoking cessation partnering by technology type

Chapter 3 - Average deal terms for smoking cessation

3.1 Introduction
3.2 Average deal terms for smoking cessation
3.3 Smoking cessation headline values with median calculation
3.4 Smoking cessation upfront values with median calculation
3.5 Smoking cessation milestone values with median calculation
3.6 Smoking cessation royalty rates with median calculation

Chapter 4 - Active smoking cessation dealmakers

4.1. Introduction
4.2 Most active smoking cessation dealmakers
4.3. Top smoking cessation deals by value
4.4 Big pharma deal activity
4.5 Big biotech deal activity

Chapter 5 - Smoking cessation dealmaking directory

5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By industry sector
5.5. By stage of development
5.6. By technology type

Chapter 6 - Partnering resource center

6.1. Online partnering
6.2. Partnering events
6.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Smoking cessation partnering since 2010
Figure 2: Smoking cessation dealmaking activity- 2010 to 2015
Figure 3: Smoking cessation partnering by deal type since 2010
Figure 4: Smoking cessation partnering by industry sector since 2010
Figure 5: Smoking cessation partnering by stage of development since 2010
Figure 6: Smoking cessation partnering by technology type since 2010
Figure 7: Smoking cessation deals with a headline value
Figure 8: Smoking cessation deals with upfront payment values
Figure 9: Smoking cessation deals with milestone payments
Figure 10: Smoking cessation deals with royalty rates, %
Figure 11: Top smoking cessation deals by value since 2010
Figure 12: Big pharma - top 50 - smoking cessation deals 2010 to 2015
Figure 13: Big pharma smoking cessation deal frequency - 2010 to 2015
Figure 14: Big biotech - top 50 - smoking cessation deals 2010 to 2015
Figure 15: Big biotech smoking cessation deal frequency - 2010 to 2015
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Sleep Aids: Technologies and Global Markets

Sleep Aids: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review ...

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021. ...

Flavored and Functional Water Market - Brazil Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Flavored and Functional Water Market - Brazil Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Brazil Flavored and Functional Water Market: Overview and Trends Transparency Market Research (TMR) offers 8-year forecast for the Brazil flavored and functional water market between 2016 and 2024. In ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry in Malaysia

  • November 2016
    10 pages
  • OTC  

  • Malaysia  

View report >

Pain Relief Industry in the US

  • November 2016
    31 pages
  • Pain Relief  

    Stroke  

  • United States  

View report >

OTC Markets in Australia

  • November 2016
    4 pages
  • Vitamin  

  • Australia  

    Oceania  

    China  

View report >

Otc Markets In India

24 days ago

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.